chr7-100105959-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_004722.4(AP4M1):​c.930G>A​(p.Arg310Arg) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000616 in 1,614,142 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00064 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00061 ( 10 hom. )

Consequence

AP4M1
NM_004722.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.02884
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 3.38

Publications

4 publications found
Variant links:
Genes affected
AP4M1 (HGNC:574): (adaptor related protein complex 4 subunit mu 1) This gene encodes a subunit of the heterotetrameric AP-4 complex. The encoded protein belongs to the adaptor complexes medium subunits family. This AP-4 complex is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs from the trans-golgi network to the endosomal-lysosomal system. [provided by RefSeq, Jul 2008]
AP4M1 Gene-Disease associations (from GenCC):
  • AP-4 deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 50
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • AP4-related intellectual disability and spastic paraplegia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.166).
BP6
Variant 7-100105959-G-A is Benign according to our data. Variant chr7-100105959-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 218652.
BP7
Synonymous conserved (PhyloP=3.38 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000644 (98/152270) while in subpopulation SAS AF = 0.00228 (11/4830). AF 95% confidence interval is 0.00128. There are 0 homozygotes in GnomAd4. There are 56 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP4M1NM_004722.4 linkc.930G>A p.Arg310Arg splice_region_variant, synonymous_variant Exon 12 of 15 ENST00000359593.9 NP_004713.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP4M1ENST00000359593.9 linkc.930G>A p.Arg310Arg splice_region_variant, synonymous_variant Exon 12 of 15 1 NM_004722.4 ENSP00000352603.4

Frequencies

GnomAD3 genomes
AF:
0.000651
AC:
99
AN:
152152
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.000943
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000736
AC:
185
AN:
251490
AF XY:
0.000883
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000954
Gnomad ASJ exome
AF:
0.00208
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00134
Gnomad NFE exome
AF:
0.000272
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000613
AC:
896
AN:
1461872
Hom.:
10
Cov.:
33
AF XY:
0.000682
AC XY:
496
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33480
American (AMR)
AF:
0.00107
AC:
48
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00203
AC:
53
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.00225
AC:
194
AN:
86256
European-Finnish (FIN)
AF:
0.000824
AC:
44
AN:
53408
Middle Eastern (MID)
AF:
0.0182
AC:
105
AN:
5768
European-Non Finnish (NFE)
AF:
0.000342
AC:
380
AN:
1112004
Other (OTH)
AF:
0.000977
AC:
59
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
51
102
154
205
256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000644
AC:
98
AN:
152270
Hom.:
0
Cov.:
32
AF XY:
0.000752
AC XY:
56
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41566
American (AMR)
AF:
0.00144
AC:
22
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4830
European-Finnish (FIN)
AF:
0.000943
AC:
10
AN:
10610
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000412
AC:
28
AN:
68006
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000642
Hom.:
1
Bravo
AF:
0.000491
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000981
EpiControl
AF:
0.000533

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Jul 17, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 19, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Uncertain:1
Jan 28, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

AP4M1-related disorder Benign:1
Feb 11, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Apr 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AP4M1: BP4, BP7 -

Hereditary spastic paraplegia 50 Benign:1
Dec 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
10
DANN
Benign
0.75
PhyloP100
3.4
Mutation Taster
=56/44
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.029
dbscSNV1_RF
Benign
0.22
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141754568; hg19: chr7-99703582; API